These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 2573213
21. Effect of beta-blockade on right ventricular performance in patients with and without right ventricular dysfunction due to coronary artery disease. Singh A, Alpert MA, Sanfelippo JF, Mukerji V, Villarreal D, Holmes RA, Sunderrajan EV, Morgan RJ. Arch Intern Med; 1986 Nov; 146(11):2135-9. PubMed ID: 2877643 [Abstract] [Full Text] [Related]
26. Efficacy and safety of carvedilol in comparison with nifedipine sustained-release in chronic stable angina. van der Does R, Eberhardt R, Derr I, Ehmer B. J Cardiovasc Pharmacol; 1992 Nov; 19 Suppl 1():S122-7. PubMed ID: 1378139 [Abstract] [Full Text] [Related]
27. Improvement of left ventricular contractility and relaxation with the beta 1-adrenergic receptor partial agonist xamoterol at rest and during exercise in patients with postinfarction left ventricular dysfunction. A placebo-controlled randomized trial. de Feyter PJ, Serruys PW, Suryapranata H. Circulation; 1990 Feb; 81(2 Suppl):III99-106. PubMed ID: 1967562 [Abstract] [Full Text] [Related]
28. Value of carvedilol in congestive heart failure secondary to coronary artery disease. Das Gupta P, Broadhurst P, Raftery EB, Lahiri A. Am J Cardiol; 1990 Nov 01; 66(15):1118-23. PubMed ID: 1977300 [Abstract] [Full Text] [Related]
29. Effects of carvedilol on left ventricular function and arrhythmias during repeated short-time myocardial ischemia in experimental pigs. Höher M, Friedrich M, Sommer T, Marten A, Ehmer B, Hombach V, Hirche H. Z Kardiol; 1989 Nov 01; 78 Suppl 3():7-15. PubMed ID: 2573214 [Abstract] [Full Text] [Related]
34. Experimental and clinical pharmacology of carvedilol and other drugs combining vasodilation and beta-adrenoceptor antagonism in a single molecule. Strein K, Sponer G. Z Kardiol; 1990 Nov 01; 79 Suppl 3():89-98. PubMed ID: 1983054 [Abstract] [Full Text] [Related]
35. The effects of intravenous carvedilol, a new multiple action vasodilatory beta-blocker, in congestive heart failure. DasGupta P, Broadhurst P, Lahiri A. J Cardiovasc Pharmacol; 1991 Nov 01; 18 Suppl 4():S12-6. PubMed ID: 1721973 [Abstract] [Full Text] [Related]
38. Can intravenous beta-blockade predict long-term hemodynamic benefit in chronic congestive heart failure secondary to ischemic heart disease? A comparison of intravenous with oral carvedilol. DasGupta P, Lahiri A. J Cardiovasc Pharmacol; 1992 Nov 01; 19 Suppl 1():S62-7. PubMed ID: 1378153 [Abstract] [Full Text] [Related]
39. A comparison of carvedilol with a combination of propranolol and isosorbide dinitrate in the chronic treatment of stable angina. Nahrendorf W, Rading A, Steinig G, van der Does R, Schlote A. J Cardiovasc Pharmacol; 1992 Nov 01; 19 Suppl 1():S114-6. PubMed ID: 1378136 [Abstract] [Full Text] [Related]
40. Effect of beta blockade with betaxolol on left ventricular systolic function in chronic stable angina pectoris and left ventricular dysfunction. Alpert MA, Singh A, Holmes RA, Sanfelippo JF, Flaker GC, Villarreal D, Mukerji V, Morgan RJ. Am J Cardiol; 1986 Apr 01; 57(10):721-4. PubMed ID: 2870631 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]